Ray Kanagawa Selected Research

imarikiren hydrochloride

1/2020	Development of a novel murine heart failure model overexpressing human renin and angiotensinogen.
1/2018	TAK-272 (imarikiren), a novel renin inhibitor, improves cardiac remodeling and mortality in a murine heart failure model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ray Kanagawa Research Topics

Disease

3	Heart Failure 01/2020 - 10/2016
2	Cardiomegaly (Heart Hypertrophy) 01/2020 - 01/2018
1	Hypertension (High Blood Pressure) 10/2016
1	Chronic Renal Insufficiency 10/2016

Drug/Important Bio-Agent (IBA)

3	ReninIBA 01/2020 - 10/2016
2	imarikiren hydrochlorideIBA 01/2020 - 01/2018
2	Renin InhibitorsIBA 01/2020 - 01/2018
2	CalsequestrinIBA 01/2020 - 01/2018
2	EnzymesIBA 01/2020 - 01/2018
1	Pharmaceutical PreparationsIBA 01/2020
1	AngiotensinogenIBA 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	aliskiren FDA Link 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018
1	Aspartic Acid ProteasesIBA 10/2016